Vonwicks Czelestakov Onyango: The Anticoagulation Dilemma in Ulcerative Colitis
Vonwicks Czelestakov Onyango, Internal Medicine Physician at St. Joseph Rift Valley Hospital, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in IJSRM, adding:
“Ulcerative colitis patients have a 2-3 fold increased risk of developing acute venous thromboembolic disease (DVT and PE).
This is especially true when they are in severe acute flare ups.
Which then brings in the conundrum: they need therapeutic anticoagulation (whose main risk is bleeding diatheses) yet they are presently bleeding from the acute flare up (in form of multiple episodes of bloody stools and hematochezia!).
The evidence supports offering them therapeutic anticoagulation anyway, as we discuss in this case write-up.”
Title: Acute Severe Flare-up of Ulcerative Colitis Complicated by Acute Deep Venous Thrombosis in a Rural Kenyan Hospital
Authors: Vonwicks C Onyango, Collins Paul Malalu, Nicholas Auma Auma, Anne Wambui Theuri, William Charles Fryd
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering